168
Views
4
CrossRef citations to date
0
Altmetric
Review Article

Cardiovascular phenotype in extremely low birth weight infants: long-term consequences

, , , &
Pages 3-5 | Published online: 30 Aug 2011

References

  • Martin JA, Kung HC, Mathews TJ, Hoyert DL, Strobino DM, Guyer B, Sutton SR. Annual summary of vital statistics: 2006. Pediatrics 2008;121:788–801.
  • MacDorman MF, Mathews TJ. Behind international rankings of infant mortality: how the United States compares with Europe. Int J Health Serv 2010;40:577–588.
  • National Institute of Child Health and Development (NICHD). Follow-up care of high-risk infants. Pediatrics 2004;114:1377–1397
  • Barrington KJ. Umbilical artery catheters in the newborn: effects of position of the catheter tip. Cochrane Database Syst Rev 2000;(2):CD000505
  • Hamrick SE, Hansmann G. Patent ductus arteriosus of the preterm infant. Pediatrics 2010;125:1020–1030.
  • Guimarães H, Rocha G, Tomé T, Anatolitou F, Sarafidis K, Fanos V. Non-steroid anti-inflammatory drugs in the treatment of patent ductus arteriosus in European newborns. J Matern Fetal Neonatal Med 2009;22 Suppl 3:77–80.
  • Lemmers PM, Toet MC, van Bel F. Impact of patent ductus arteriosus and subsequent therapy with indomethacin on cerebral oxygenation in preterm infants. Pediatrics 2008;121:142–147.
  • McCurnin D, Seidner S, Chang LY, Waleh N, Ikegami M, Petershack J, Yoder B, et al. Ibuprofen-induced patent ductus arteriosus closure: physiologic, histologic, and biochemical effects on the premature lung. Pediatrics 2008;121:945–956.
  • Ohlsson A, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews 2010, Issue 4. Art. No.: CD003481. DOI: 10.1002/14651858.CD003481.pub4
  • Antonucci R, Bassareo P, Zaffanello M, Pusceddu M, Fanos V. Patent ductus arteriosus in the preterm infant: new insights into pathogenesis and clinical management. J Matern Fetal Neonatal Med 2010;23 Suppl 3:34–37.
  • Whitfield MF, Grunau RE. Teenagers born at extremely low birth weight. Paediatr Child Health 2006;11:275–277.
  • Dalziel SR, Parag V, Rodgers A, Harding JE. Cardiovascular risk factors at age 30 following pre-term birth. Int J Epidemiol 2007;36:907–915.
  • Puddu M, Fanos V, Podda F, Zaffanello M. The kidney from prenatal to adult life: perinatal programming and reduction of number of nephrons during development. Am J Nephrol 2009;30:162–170.
  • Luyckx VA, Brenner BM. Low birth weight, nephron number, and kidney disease. Kidney Int Suppl 2005:S68–S77.
  • Barker DJ, Osmond C, Golding J, Kuh D, Wadsworth ME. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ 1989;298:564–567.
  • Bassareo PP, Fanos V, Puddu M, Cadeddu C, Balzarini M, Mercuro G. Significant QT interval prolongation and long QT in young adult ex preterm newborns with extremely low birth weight. J Matern Fetal Neonatal Med 2011, in press. [Epub ahead of print].
  • Corvaglia L, Faldella G, Rotatori R, Lanari M, Capretti MG, Salvioli GP. Intrauterine growth retardation is a risk factor for cisapride-induced QT prolongation in preterm infants. Cardiovasc Drugs Ther 2004;18:371–375.
  • Dubin A, Kikkert M, Mirmiran M, Ariagno R. Cisapride associated with QTc prolongation in very low birth weight preterm infants. Pediatrics 2001;107:1313–1316.
  • Welsh L, Kirkby J, Lum S, Odendaal D, Marlow N, Derrick G, Stocks J; EPICure Study Group. The EPICure study: maximal exercise and physical activity in school children born extremely preterm. Thorax 2010;65:165–172.
  • Saigal S, Stoskopf B, Boyle M, Paneth N, Pinelli J, Streiner D, Goddeeris J. Comparison of current health, functional limitations, and health care use of young adults who were born with extremely low birth weight and normal birth weight. Pediatrics 2007;119:e562–e573.
  • Bassareo PP, Fanos V, Puddu M, Demuru P, Cadeddu F, Balzarini M, Mercuro G. Reduced brachial flow-mediated vasodilation in young adult ex extremely low birth weight preterm: a condition predictive of increased cardiovascular risk? J Matern Fetal Neonatal Med 2010;23 Suppl 3:121–124.
  • Vapaatalo H, Mervaala E. Clinically important factors influencing endothelial function. Med Sci Monit 2001;7:1075–1085.
  • Bassareo PP, Puddu M, Flore G, Deidda M, Manconi E, Melis A, Fanos V, Mercuro G. Could ADMA levels in young adults born preterm predict an early endothelial dysfunction? Int J Cardiol 2011 [Epub ahead of print].
  • Ueda S, Yamagishi S, Kaida Y, Okuda S. Asymmetric dimethylarginine may be a missing link between cardiovascular disease and chronic kidney disease. Nephrology (Carlton) 2007;12:582–590.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.